A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-561
Published Online: 2014-08-02
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halperin, Daniel M
Phan, Alexandria T
Hoff, Ana O
Aaron, Marie
Yao, James C
Hoff, Paulo M
License valid from 2014-08-02
Article History
Received: 6 March 2014
Accepted: 22 July 2014
First Online: 2 August 2014